ArticleMolecular therapy. Nucleic acids2015

Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer.

Masayuki Hiraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.